SCM
NERV icon

Segantii Capital Management’s Minerva Neurosciences NERV Stock Holding History

Segantii Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,303
Closed -$110K – 86
2016
Q1 		$110K Buy
+2,303
New +$98.3K 0.05% 134

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Segantii Capital Management's NERV Position: Q2 2016 in Review

Segantii Capital Management sold out of Minerva Neurosciences (NERV) in Q2 2016, closing a stake of 2,303 shares — an estimated $110K sold.

Segantii Capital Management first reported a position in NERV in Q1 2016 and held it in 1 quarter. The position peaked at $110K in Q1 2016. 63 funds tracked by Wall St. Rank hold NERV as of Q2 2016.

  • Segantii Capital Management reported no remaining Minerva Neurosciences position as of Q2 2016 after selling out during the quarter.
  • Segantii Capital Management sold 2,303 Minerva Neurosciences shares in Q2 2016, an estimated $110K.
  • Segantii Capital Management first reported a position in Minerva Neurosciences in Q1 2016 and held it in 1 quarter.
  • Segantii Capital Management's Minerva Neurosciences position peaked at $110K in Q1 2016.
  • 63 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2016.

Based on Segantii Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.